
Marijuana use doubles risk of dying from heart disease, large study finds
Heart disease
Chronic diseasesFacebookTweetLink
Follow
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Using marijuana doubles the risk of dying from heart disease, according to a new analysis of pooled medical data involving 200 million people mostly between the ages of 19 and 59.
'What was particularly striking was that the concerned patients hospitalized for these disorders were young (and thus, not likely to have their clinical features due to tobacco smoking) and with no history of cardiovascular disorder or cardiovascular risk factors,' said senior author Émilie Jouanjus, an associate professor of pharmacology at the University of Toulouse, France, in an email.
Compared to nonusers, those who used cannabis also had a 29% higher risk for heart attacks and a 20% higher risk for stroke, according to the study published Tuesday in the journal Heart.
'This is one of the largest studies to date on the connection between marijuana and heart disease, and it raises serious questions about the assumption that cannabis imposes little cardiovascular risk,' said pediatrician Dr. Lynn Silver, a clinical professor of epidemiology and biostatistics at University of California, San Francisco.
'Getting this right is critically important because cardiovascular disease is the top cause of death both in the United States and globally,' said Silver, who is also senior adviser at the Public Health Institute, a nonprofit public health organization that analyzes marijuana policy and legalization.
Silver is the coauthor of an editorial published with the paper that calls for change in how cannabis is viewed by health professionals, regulatory bodies and the public at large.
'Clinicians need to screen people for cannabis use and educate them about its harms, the same way we do for tobacco, because in some population groups it's being used more widely than tobacco,' she said. 'Our regulatory system, which has been almost entirely focused on creating legal infrastructure and licensing legal, for-profit (cannabis) businesses, needs to focus much more strongly on health warnings that educate people about the real risks.'
The new systematic review and meta-analysis analyzed medical information from large, observational studies conducted in Australia, Egypt, Canada, France, Sweden and the US between 2016 and 2023.
Those studies did not ask people how they used cannabis — such as via smoking, vaping, dabbing, edibles, tinctures or topicals. (Dabbing involves vaporizing concentrated cannabis and inhaling the vapor.) However, 'based on epidemiological data, it is likely that cannabis was smoked in the vast majority of cases,' Jouanjus said.
Smoking tobacco is a well-known cause of heart disease — both the smoke and the chemicals in tobacco damage blood vessels and increase clotting, according to the US Centers for Disease Control and Prevention.
Therefore, it is not surprising that smoking, vaping or dabbing cannabis could do the same, Silver said: 'Any of the many ways of inhaling cannabis are going to have risks to the user, and there's also secondhand smoke risks, which are similar to tobacco.'
The notion that smoking cannabis is less harmful because it's 'natural' is just wrong, Dr. Beth Cohen, professor of medicine at the University of California, San Francisco, told CNN in a prior interview.
'When you burn something, whether it is tobacco or cannabis, it creates toxic compounds, carcinogens, and particulate matter that are harmful to health,' Cohen said in an email.
However, edibles may also play a role in heart disease, according to a May 2025 study.
People who consumed edibles laced with tetrahydrocannabinol, or THC, showed signs of early cardiovascular disease similar to tobacco smokers.
'We found that vascular function was reduced by 42% in marijuana smokers and by 56% in THC-edible users compared to nonusers,' Dr. Leila Mohammadi, an assistant researcher in cardiology at the University of California, San Francisco, told CNN in a prior interview.
None of the studies included in the new meta-analysis asked users about the potency of THC in the products they consume. Even if they had, that information would be quickly outdated, Silver said.
'The cannabis market is a moving target. It is getting more potent every day,' she said.
'What's being sold to people today in California is 510 times stronger than what it was in the 1970s. Concentrates can be 99% pure THC. Vapes are over 80% THC.
'A variety of chemically extracted cannabinoids can be almost pure THC, and all of these just have very different effects on people than smoking a joint in the 1970s.'
Higher potency weed is contributing to a host of problems, including an increase in addiction — a July 2022 study found consuming high-potency weed was linked to a fourfold increased risk of dependence.
In the United States, about 3 in 10 people who use marijuana have cannabis use disorder, the medical term for marijuana addiction, according to the CDC.
'We know that more potent cannabis makes people more likely to become addicted,' Silver said. 'We know that more potent cannabis makes people more likely to develop psychosis, seeing and hearing things that aren't there, or schizophrenia. Habitual users may also suffer from uncontrollable vomiting.'
The rise in potency is one reason that the current study may not have captured the full extent of the risk of marijuana for heart disease, Jouanjus said: 'We are afraid that the association might be even stronger than that reported.'
While science continues to study the risk, experts say it's time to think twice about the potential harms of cannabis use — especially if heart disease is a concern.
'If I was a 60-year-old person who had some heart disease risk, I would be very cautious about using cannabis,' Silver said. 'I've seen older people who are using cannabis for pain or for sleep, some of whom have significant cardiovascular risk, or who have had strokes or had heart attacks or had angina, and they have no awareness that this may be putting them at greater risk.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
I'm in my 50s and have recently developed brown spots. Can anything be done about hyperpigmentation?
Dermatologist Marisa Garshick explains how UV exposure, hormones and inflammation cause dark spots — and what can reverse them. I'm in my early 50s and have recently developed some serious brown sun spots on my cheeks, forehead and chest. At first, I thought they were freckles, but then I realized they looked a lot smudgier and more blob-like than the freckles I had when I was younger. What can I do to get rid of them? Thanks! Dear Aging Into Age Spots, It's true that at one time you may have sprouted a sprinkling of cute, Punky Brewster-esque freckles, but into middle age you get less-cute sun damage, also known as the definitely unadorable-sounding hyperpigmentation. "Hyperpigmentation is the result of an increase in melanin and can result from UV exposure or environmental stressors that lead to free radical damage and manifest as brown spots," board-certified dermatologist Dr. Marisa Garshick told me last month. "It can arise in the setting of what is known as post-inflammatory hyperpigmentation, which refers to discoloration that occurs as a result of skin injury or skin inflammation, such as after an acne breakout or a bug bite. Another type of hyperpigmentation is melasma, which typically occurs on sun-exposed areas of the face and can be triggered by hormonal changes." While hyperpigmentation is super common, the bad news is it won't go away on its own. But the good news? Garshick says there are loads of treatments for it, some of which you can try at home. The first thing to do if you notice new spots on your face (or body) is head to a dermatologist's office. After the doctor has determined that the skin discoloration is benign, you can decide on the best course of treatment together. In-office treatments for hyperpigmentation include lower-cost chemical peels or pricier services like lasers and light-based devices. Different forms of hyperpigmentation will respond better to different treatments, so a consultation with an expert is essential to find the right fit for your skin. And while I was initially skeptical, Garshick assures me that at-home remedies can also be effective to brighten dark spots, though the effect will be more subtle and happen over time. Of the best over-the-counter products, she's seen a good result with both inexpensive drugstore creams like Eucerin's thiamiadol dark spot corrector and pricier serums like Mother Science's award-winning Molecular Hero, which contains a patented form of malassezin and which was used — in addition to sunscreen — on the set of the most recent season of The White Lotus to keep the actors' skin from developing further damage in the hot Thailand sun. Other ingredients that have been proved to promote clarity in your complexion are vitamin C and retinol. Most important of all, to avoid further brown spots, Garschick says it's crucial to apply sunscreen whenever you're planning on being outside in the sun and to reapply it every two hours for optimal protection. "I'd also say to avoid peak hours in the sun and seek shade whenever possible," she the daily Crossword
Yahoo
34 minutes ago
- Yahoo
Monroe Capital Supports Summit Professional Education's Acquisition of Herman & Wallace Pelvic Rehabilitation Institute
CHICAGO, August 20, 2025--(BUSINESS WIRE)--Monroe Capital LLC ("Monroe") announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility and equity co-investment to support the acquisition of Herman & Wallace Pelvic Rehabilitation Institute ("Herman & Wallace") by Summit Professional Education ("Summit"), an existing portfolio company of Avathon Capital. Founded in 2005 and headquartered in Seattle, WA, Herman & Wallace provides comprehensive, hands-on and evidence-based curricula for treating pelvic floor dysfunction in all people throughout the life cycle. Founded in 2004 and headquartered in Franklin, TN, Summit is a provider of in-person and online continuing and professional education courses for physical therapists and assistants, occupational therapists and assistants, and speech language pathologists. Together, Herman & Wallace and Summit will expand access, innovate clinician education, and continue to raise the standard of care in pelvic health. This transaction is representative of Monroe's ability to provide comprehensive "one-stop" solutions for private equity sponsors seeking debt and equity capital to finance their acquisitions and recapitalizations. About Monroe Capital Monroe Capital LLC ("Monroe") is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, alternative credit solutions, structured credit, real estate and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly partner to business owners, management, and both private equity and independent sponsors. Monroe's platform offers a wide variety of investment products for both institutional and high net worth investors with a focus on generating high quality "alpha" returns irrespective of business or economic cycles. The firm is headquartered in Chicago and has 11 locations throughout the United States, Asia and Australia. Monroe has been recognized by both its peers and investors with various awards including Private Debt Investor as the 2024 Lower Mid-Market Lender of the Year, Americas and 2023 Lower Mid-Market Lender of the Decade; Inc.'s 2024 Founder-Friendly Investors List; Global M&A Network as the 2023 Lower Mid-Markets Lender of the Year, U.S.A.; DealCatalyst as the 2022 Best CLO Manager of the Year; Korean Economic Daily as the 2022 Best Performance in Private Debt – Mid Cap; Creditflux as the 2021 Best U.S. Direct Lending Fund; and Pension Bridge as the 2020 Private Credit Strategy of the Year. For more information and important disclaimers, please visit View source version on Contacts For more information, please contact: Zia UddinMonroe Capital LLC312-523-2374zuddin@ Daniel AbramsonBackBay Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Fox News
37 minutes ago
- Fox News
American Academy of Pediatrics breaks with CDC, recommends COVID vaccine for kids
Dr. Dyan Hes joins 'Fox & Friends First' to discuss her take on the American Academy of Pediatrics' recommendation and why some are optimistic about an experimental cancer vaccine.